Skip to main content

Closed

KTTA: Pasithea Therapeutics Corp. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

10thpctl

Volume

0.31×avg

Market Cap

3.42MUSD

P/E Ratio

-0.2TTM

Div Yield

-ann

Pasithea Therapeutics Corp.

KTTANASDAQ Capital Market·USD·Closed

Pasithea Therapeutics Corp.

KTTANASDAQ·USD·Closed

$0.46

+3.58%

$0.46

+$0.02 (3.58%)

52W Range

10thpctl

Volume

0.31×avg

Mkt Cap

3.42MUSD

P/E

-0.2TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings